Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.

Natalia RompotiTheognosia VergouIrene StefanakiCharitomeni VavouliIoannis-Alexios KoumprentziotisPantelis PanagakisMarina PapoutsakiMaria PolitouAngeliki BefonFiori KoustaEleni LazouMaria ZaimiVasiliki ChasapiAlexander StratigosElectra Nicolaidou

Published in: International journal of dermatology (2024)

Keyphrases

randomized controlled trial
drug induced
systematic review
coronary artery disease
high intensity
early onset
free survival
adverse drug
electronic health record